GLP-1 Microdosing and Sublingual Drops: What to Know
Microdosing means a lower dose of semaglutide or tirzepatide than standard weight programs use, and sublingual drops are a needle-free form placed under the tongue. Both appeal to women who want a gentler option, but research on either is limited.
GLP-1 microdosing means taking a lower weekly dose of semaglutide or tirzepatide than standard weight programs use, usually for a gentler start, for fewer side effects or for maintenance. Sublingual drops are a needle-free form of tirzepatide placed under the tongue each day. Both are popular with women who want a softer approach, but there is no standard definition of microdosing, little research on very low doses, and no published large trials of tirzepatide taken under the tongue. A licensed provider can help you decide whether either fits.
Key takeaways
- The large weight-loss trials studied standard injectable doses that were raised step by step, not microdoses or drops.
- Microdosing may suit women who are sensitive to side effects or who are maintaining after a standard program.
- Sublingual drops avoid needles, but how much medicine is absorbed this way is not established.
- Both carry the same safety rules as standard GLP-1 care, including not using during pregnancy.
- At Golden Glow, microdose semaglutide is $170 a month, microdose tirzepatide is $235 a month and tirzepatide drops start at $225 a month.
What microdosing means
In the STEP 1 trial of semaglutide and the SURMOUNT-1 trial of tirzepatide, people started on a low dose that was raised every few weeks to a target dose. That slow increase is meant to limit nausea and stomach upset.
Microdosing uses lower doses than those targets, sometimes staying near the starting range. People choose it for different reasons: a gentler first few months, a history of strong side effects, a smaller amount of weight to lose, or maintenance after reaching a goal. Because the large trials did not test these doses as a long-term plan, the expected results are not known, and a provider sets and adjusts the dose for you.
What sublingual drops are
Sublingual means under the tongue. Some medicines are absorbed well this way, but peptides like tirzepatide are large molecules, and there are no published large human trials showing how well tirzepatide drops are absorbed or how they compare with injections.
Drops can still make sense for someone who qualifies for a GLP-1 and will not use needles, as long as they understand the evidence gap. Golden Glow offers a 15 mL starting size for $225 a month and a 30 mL maintenance size for $300 a month.
Who might consider each option
| Microdose GLP-1 | Tirzepatide drops | |
|---|---|---|
| How it is taken | Injection under the skin, once a week | Drops under the tongue, once a day |
| Why women choose it | Gentler start, side effects, maintenance | No needles |
| Research behind it | Limited for very low doses | No published large trials for this form |
| Golden Glow price | $170 to $235 a month | $225 to $300 a month |
Safety is the same
A lower dose or a different form does not remove the safety rules. GLP-1 medicines are not for use during pregnancy or for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Stomach side effects are still possible. Get help right away for severe stomach pain that does not go away or signs of dehydration.
Compounded GLP-1 medicines are prepared by licensed US pharmacies for individual patients and are not FDA-approved. The FDA has received reports of dosing errors with compounded GLP-1 medicines, so measure every dose exactly as your label explains and ask your care team if anything is unclear.
Frequently asked questions
Will a microdose still help me lose weight?
It may help some people, but low doses were not tested as a long-term plan in the large trials, so results are not known and vary from person to person.
Are tirzepatide drops as good as injections?
That is not known. The injection is the form studied in large trials. Drops are an option for people who will not use needles and accept the evidence gap.
Can I start with a microdose and move up?
Yes. Many providers start low and adjust based on how you feel and how you are progressing toward your goals.
Do I still need an online visit?
Yes. Every GLP-1 option starts with an online visit, and a licensed provider decides whether it is appropriate for you.
Talk to a licensed provider
Curious about a gentler start? Learn about microdose GLP-1 and tirzepatide sublingual drops, or compare all GLP-1 weight loss options, then start an online visit. This article is educational and does not determine eligibility for any treatment.
Sources
- NIDDK, Prescription Medications to Treat Overweight and Obesity
- Wilding et al., Once-Weekly Semaglutide in Adults with Overweight or Obesity, N Engl J Med (2021)
- Jastreboff et al., Tirzepatide Once Weekly for the Treatment of Obesity, N Engl J Med (2022)
- FDA, FDA's concerns with unapproved GLP-1 drugs used for weight loss
- FDA, Compounding and the FDA: Questions and Answers
This article is educational and is not medical advice. Golden Glow content is written to be accurate and is reviewed against the sources above. Rx programs require an online visit with a licensed provider. Results vary.